Unique ID issued by UMIN | UMIN000008346 |
---|---|
Receipt number | R000009615 |
Scientific Title | Study of perioperative nutritional status improved by immunoenhancing enteral nutrients in patients who underwent pancreaticoduodenectomy. |
Date of disclosure of the study information | 2012/07/04 |
Last modified on | 2019/07/10 12:47:47 |
Study of perioperative nutritional status improved by immunoenhancing enteral nutrients in patients who underwent pancreaticoduodenectomy.
Nutritional intervention trials in patients who underwent pancreaticoduodenectomy.
Study of perioperative nutritional status improved by immunoenhancing enteral nutrients in patients who underwent pancreaticoduodenectomy.
Nutritional intervention trials in patients who underwent pancreaticoduodenectomy.
Japan |
Pancreatic cancer, Bile duct cancer, Duodenal cancer, Intraductal papillary mucinous neoplasm, Neuroendocrine tumor, Mesenchymal tumor
Gastroenterology | Hepato-biliary-pancreatic medicine | Gastrointestinal surgery |
Hepato-biliary-pancreatic surgery |
Malignancy
NO
To investigate the improvement of nutritional status and reduction of postoperative infectious complications by ingestion of immunoenhancing enteral nutrients in patients undergoing pancreaticoduodenectomy.
Efficacy
Body cell mass
Infectious complications, Other complications, Nutritional indexes, Length of hospital stay, Recurrence-free survival time, Overall survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Food |
Intake of immune-enhancing enteral nutrients from 2 weeks before surgery to 12 weeks after surgery. The dose of nutrients is approximately 600kcal per day.
20 | years-old | <= |
80 | years-old | > |
Male and Female
1)Patients over the age of 20, and under the age of 80
2)Patients who will undergo Pancreaticoduodenectomy
3)Patients who fully understand the study procedures and consent the document voluntary after an adequate explanation
1)Patients who have active infection
2)Patients with milk allergy
3)Patients with ileus
4)Patients whose intestinal function is not the residual
5)Patients with advanced liver dysfunction or advanced renal dysfunction
6)Patients with abnormal glucose metabolism, such as severe diabetes
7)Patients with congenital disorders of amino acid metabolism
8)Patients who were deemed inappropriate for medical reasons
80
1st name | Kiyoshi |
Middle name | |
Last name | Hasegawa |
The University of Tokyo
Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine
1138655
7-3-1 Hongo, Bunkyo-ku, Tokyo
0358143933
ichida-tky@umin.ac.jp
1st name | Akihiko |
Middle name | |
Last name | Ichida |
The University of Tokyo
Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine
1138655
7-3-1 Hongo, Bunkyo-ku, Tokyo
03-3815-5411
ichida-tky@umin.ac.jp
The University of Tokyo, Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine
None
Self funding
Clinical research support center, the university of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo
03-5800-8743
p1unit-office@umin.net
NO
2012 | Year | 07 | Month | 04 | Day |
Published
80
Completed
2012 | Year | 02 | Month | 20 | Day |
2012 | Year | 04 | Month | 26 | Day |
2012 | Year | 07 | Month | 01 | Day |
2019 | Year | 03 | Month | 31 | Day |
2012 | Year | 07 | Month | 04 | Day |
2019 | Year | 07 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009615